Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach

[1]  Robert Kudernatsch,et al.  The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy. , 2011, Drug discovery today.

[2]  T. Taxt,et al.  Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma , 2011, Proceedings of the National Academy of Sciences.

[3]  J. Nagy,et al.  Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. , 2011, Blood.

[4]  K. Giese,et al.  Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models , 2010, Clinical Cancer Research.

[5]  Jeong Won Lee,et al.  Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.

[6]  G. Elia,et al.  Endothelial-Rac1 Is Not Required for Tumor Angiogenesis unless αvβ3-Integrin Is Absent , 2010, PloS one.

[7]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[8]  Richard Heller,et al.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  John M L Ebos,et al.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. , 2009, Cancer cell.

[10]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[11]  Anne J. Ridley,et al.  Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.

[12]  D. Kwiatkowski,et al.  Regulation of Endothelial Nitric Oxide Synthase and Postnatal Angiogenesis by Rac1 , 2008, Circulation research.

[13]  Todd R. Palmby,et al.  An essential role for Rac1 in endothelial cell function and vascular development , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  G. Davis,et al.  Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling , 2008, Journal of Cell Science.

[15]  J. V. van Buul,et al.  VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. , 2007, Experimental cell research.

[16]  Michalis V. Karamouzis,et al.  Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets , 2007, Nature Reviews Drug Discovery.

[17]  B. Bryan,et al.  What tangled webs they weave: Rho-GTPase control of angiogenesis , 2007, Cellular and Molecular Life Sciences.

[18]  J Teissié,et al.  In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery , 2007, Gene Therapy.

[19]  Baolin Zhang,et al.  Rac signaling in tumorigenesis and as target for anticancer drug development. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[20]  P. Opolon,et al.  Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. , 2006, Human gene therapy.

[21]  X. Yao,et al.  Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel‐Lindau suppression and HIF1α activation , 2006, International journal of cancer.

[22]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[23]  Amanda Y. Chan,et al.  Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion , 2005, Oncogene.

[24]  J. Field,et al.  Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells. , 2005, Cancer letters.

[25]  Alan Hall,et al.  Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.

[26]  Sofia D. Merajver,et al.  Multifaceted Role of Rho Proteins in Angiogenesis , 2005, Journal of Mammary Gland Biology and Neoplasia.

[27]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[28]  J. Lacal,et al.  Rho GTPases: potential candidates for anticancer therapy. , 2004, Cancer letters.

[29]  A. Hall,et al.  Rac regulates endothelial morphogenesis and capillary assembly. , 2002, Molecular biology of the cell.

[30]  G. Davis,et al.  The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. , 2002, Journal of cell science.

[31]  E. Lengyel,et al.  Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b , 2000, Oncogene.

[32]  B. Kaina,et al.  Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.

[33]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[34]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[35]  A. Hall,et al.  Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.